The Sleep/Alzheimer’s/Anavex Connection
A new report lays out details of how poor sleep may induce, cause Alzheimer’s disease. Lot’s of details here:
https://www.sciencenews.org/article/sleep-brain-alzheimers-plaques-protein?utm_source=email&utm_medium=email&utm_campaign=latest-newsletter-v2
We note that improved sleep was an outcome of the first, short Anavex 2-73 clinical trial, in Australia. Sleep problems, deficiencies, are a typical symptom of Alzheimer’s disease, markedly and negatively affecting patient well-being.
Might the following scenario eventually be discovered? Anavex 2-73 is prescribed to middle aged or older people when the very first, very minor symptoms of Alzheimer’s appear. These folks are still in good health, fully functional in every mental capacity. But memory is starting to slip. And, these folks are no longer sleeping well.
After taking the Anavex 2-73, healthful sleep resumes, and continues with Anavex dosing. Then, it is discovered that full, fast-acting memory has been restored.
In this case, the Anavex drug functions because it allows the body to sleep normally, thereby allowing it to also clear the protein wastes that inhibit nerve functions.
Anavex causes, allows proper sleep. The resulting healthful sleep then allows the body to normally clear toxic protein wastes. Alzheimer’s disease onset and progression are therefore thwarted.
Might the Anavex/good sleep connection be at least one reason the Australians in the early Anavex 2-73 have almost universally elected to continue with the drug?
Market Data 
Markets 
AI
